Source: Eur Respir J, 59 (2) 2103114; 10.1183/13993003.03114-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Vivienne Kahlmann, Catharina C. Moor, Jelle R. Miedema, Marlies S. Wijsenbeek. Comparison of the treatment guidelines for sarcoidosis: common sense in the search for evidence. Eur Respir J, 59 (2) 2103114; 10.1183/13993003.03114-2021

Member's Comments

No comment yet.

Related content which might interest you: Prescriptions for treatment in patients with PCD: does clinical routine match recommendations? Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum Year: 2020 Cough clinical practice guidelines: A critical review of scientific evidence and recommendations Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Definition of COPD: based on evidence or opinion? Source: Eur Respir J 2008; 31: 681-682 Year: 2008 Evidence provided by recent meta-analyses on treatment: what is new? Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET) Year: 2012 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Guidelines versus clinical practice in the treatment of COPD: a reappraisal Source: Eur Respir J 2006; 27: 656 Year: 2006 COPD guidelines in relation to infections: a critical analysis Source: Breathe 2009; 5: 317-321 Year: 2009 Defining high probability of an asthma diagnosis in primary care: results from an expert consensus workshop Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 COPD guidelines in relation to infections: a critical analysis Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008 Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice Source: Eur Respir J 2013; 41: 1252-1256 Year: 2013 Describing what evidence and outcomes to use in guidelines Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008 Is there enough evidence to support recommendations on tuberculosis control? Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Impact of guidelines in the outcomes of CAP: the evidence Source: Annual Congress 2013 –MS6 Community-acquired pneumonia: moving from guidelines to clinical practice Year: 2013 Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion Source: Eur Respir J 2015; 45: 1170-1173 Year: 2015 Evidence-based treatment strategies in idiopathic pulmonary fibrosis Source: Eur Respir Rev 2013; 22: 163-168 Year: 2013 WHO 2019 guidelines on drug-resistant tuberculosis treatment: based on evidence or expert opinion? Source: Eur Respir J, 55 (3) 1901935; 10.1183/13993003.01935-2019 Year: 2020 Different definitions in childhood asthma: how dependable is the dependent variable? Source: Eur Respir J 2010; 36: 48-56 Year: 2010 2015 guidelines to treat IPF: an update of the 2011 guidelines - specific treatment recommendations Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis Year: 2015